These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17981589)
1. Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Florio T Front Biosci; 2008 Jan; 13():822-40. PubMed ID: 17981589 [TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs and radiopeptides in cancer therapy. Froidevaux S; Eberle AN Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036 [TBL] [Abstract][Full Text] [Related]
4. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin and its receptor family. Patel YC Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861 [TBL] [Abstract][Full Text] [Related]
6. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling. Leu FP; Nandi M; Niu C Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806 [TBL] [Abstract][Full Text] [Related]
7. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET Med Oncol; 2004; 21(3):285-95. PubMed ID: 15456957 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118 [TBL] [Abstract][Full Text] [Related]
9. Function and expression of somatostatin receptors of the endocrine pancreas. Strowski MZ; Blake AD Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine neoplasms and somatostatin receptor subtypes expression. Hankus J; Tomaszewska R Nucl Med Rev Cent East Eur; 2016; 19(2):111-7. PubMed ID: 27479788 [TBL] [Abstract][Full Text] [Related]
11. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788 [TBL] [Abstract][Full Text] [Related]
12. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors. Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465 [TBL] [Abstract][Full Text] [Related]
14. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors. Vitali E; Piccini S; Trivellin G; Smiroldo V; Lavezzi E; Zerbi A; Pepe G; Lania AG Mol Cell Endocrinol; 2021 May; 527():111226. PubMed ID: 33675866 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer. Klomp MJ; Dalm SU; de Jong M; Feelders RA; Hofland J; Hofland LJ Rev Endocr Metab Disord; 2021 Sep; 22(3):495-510. PubMed ID: 33085037 [TBL] [Abstract][Full Text] [Related]
16. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line. Leu FP; Nandi M Pancreas; 2010 Nov; 39(8):1155-66. PubMed ID: 20531241 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. Cakir M; Dworakowska D; Grossman A J Cell Mol Med; 2010 Nov; 14(11):2570-84. PubMed ID: 20629989 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154 [TBL] [Abstract][Full Text] [Related]
19. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation. Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215 [TBL] [Abstract][Full Text] [Related]
20. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Sharma K; Patel YC; Srikant CB Mol Endocrinol; 1999 Jan; 13(1):82-90. PubMed ID: 9892014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]